anmelden
OMX Nordic 40
2.616,75
PKT
+0,52
PKT
+0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.06.18 | Novo Nordisk buy | UBS AG | |
| 25.06.18 | AstraZeneca Neutral | UBS AG | |
| 25.06.18 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
| 25.06.18 | Nokia Neutral | Credit Suisse Group | |
| 25.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 22.06.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.06.18 | Novo Nordisk Underweight | Barclays Capital | |
| 22.06.18 | Fortum Sell | Deutsche Bank AG | |
| 22.06.18 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 22.06.18 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Société Générale Group S.A. (SG) | |
| 22.06.18 | Novo Nordisk Hold | Commerzbank AG | |
| 21.06.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 21.06.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 21.06.18 | Fortum Neutral | Oddo Seydler Bank AG | |
| 21.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 21.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.06.18 | Nokia Neutral | BNP PARIBAS | |
| 18.06.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.06.18 | Fortum Outperform | Macquarie Research | |
| 15.06.18 | Ericsson (Telefon L.M.Ericsson) (B) Underperform | Credit Suisse Group | |
| 15.06.18 | AstraZeneca buy | Jefferies & Company Inc. | |
| 15.06.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 14.06.18 | Novo Nordisk buy | UBS AG | |
| 13.06.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 12.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 12.06.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 11.06.18 | Volvo (B) buy | Citigroup Corp. | |
| 11.06.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.06.18 | Novo Nordisk buy | UBS AG | |
| 07.06.18 | Volvo (B) Sell | UBS AG | |
| 06.06.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.06.18 | AstraZeneca buy | Deutsche Bank AG | |
| 31.05.18 | Novo Nordisk Reduce | HSBC | |
| 30.05.18 | Novo Nordisk overweight | Morgan Stanley | |
| 30.05.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.05.18 | Novo Nordisk buy | UBS AG | |
| 30.05.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.05.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 29.05.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.05.18 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |